Viewing Study NCT06133556


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2025-12-25 @ 9:18 PM
Study NCT ID: NCT06133556
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-11-15
First Post: 2023-09-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module